How to Integrate Cancer Immunotherapy Into Your Clinical Practice Pre-Annual Meeting Seminar

Starts:  Jun 1, 2017 13:00 (CT)
Ends:  Jun 2, 2017 11:00 (CT)
Presented by the American Society of Clinical Oncology (ASCO) in collaboration with the Society for Immunotherapy of Cancer

This in-depth joint educational seminar, offered prior to the 2017 ASCO Annual Meeting, will enable clinical oncologists, nurses, pharmacists, and the entire medical team to effectively offer their patients additional treatment options through immunotherapy. After the seminar, attendees will be able to apply basic immunology principles to the clinical setting; effectively identify patients who may benefit from immunotherapy; confidently manage all aspects of patient care for those receiving immunotherapy; and describe emerging drugs and concepts in the field, including the value proposition of immunotherapy agents for patients and one’s clinical practice.

SITC members are eligible for discounted registration! Please email to obtain the discount code.

Learn more about this meeting and register to attend here!

Mary L. (Nora) Disis, MDUniversity of Washington
Mario Sznol, MD – Yale School of Medicine

Seminar Agenda

Day 1: Thursday, June 1, 2017: 12:30 – 5 p.m.

12:30 – 1 p.m.


1 – 1:05 PM


Mary L. (Nora) Disis, MD

1:05 – 2:55 p.m.

Session 1: The Immune System and Cancer

Chair: TBD

Basic Principles of Tumor Immunology for the Non-Immunologist
Justin Paul Kline, MD – University of Chicago

Mechanisms of Immune Suppression
Brent Hanks, MD, PhD – Duke University Medical Center

General Principles of Integrating and Sequencing Immune Therapy With Chemotherapy, Radiation Therapy, or Targeted Therapies
Sandra Demaria, MD Weill Cornell Medical College

2:55 – 3:15 p.m. Break
3:15 – 5 p.m.

Session 2: Emerging Indications for Cancer Immunotherapy

Immunotherapy in Breast and Gynecological Malignancies
: Leisha Emens, MD, PhD – National Cancer Institute

Immunotherapy in GI Malignancies
Dung Le, MD Sidney Kimmel Comprehensive Cancer Center

Immunotherapy for the Treatment of Head and Neck Cancers
Tanguy Seiwert, MD – University of Chicago


Day 2: Friday, June 2, 2017: 7 – 11 a.m.

7 – 7:30 a.m. Breakfast

7:30 – 9:10 a.m.

Session 3: How to Integrate Immunotherapy into Clinical Practice

Chair: James Gulley, MD, PhD, FACP – National Cancer Institute

Immunotherapy for Melanoma
Jeffrey Weber, MD, PhD – NYU Langone Medical Center

Immunotherapy for the Treatment of non-small Cell Lung Cancer
Naiyer Rizvi, MD – Columbia University

Immunotherapy for the Treatment of GU Cancers
Arjun Balar, MD – NYU Langone Medical Center

Immune Checkpoint and Cell Therapies for Hematologic Malignancies
Stephen M. Ansell, MD, PhD – Mayo Clinic Cancer Center

9:10 – 9:25 a.m. Break
9:25 – 11 a.m.

Session 4: How to Integrate Immunotherapy Into Clinical Practice

Management of Adverse Events
Chair: Mario Sznol, MD – Yale School of Medicine and Yale Cancer Center

Nursing Aspects in the Clinical Management of Patients Receiving Immunotherapy
Brianna Hoffner, NPUniversity of Colorado, Denver

What Is the Value of Immunotherapy in Contemporary Oncology Practice?
Lowell E. Schnipper, MD, FASCO – Beth Israel Deaconess Medical Center

What Are the Most Promising New Immunotherapy Strategies?
Patrick Hwu, MD – MD Anderson Cancer Center

#HematologicMalignancies #GenitourinaryCancer #SkinCancer #LungCancer #GynecologicCancers #CNE #CPE #Collaboration #CollaborativeEvent #CME #GastrointestinalCancers


McCormick Place
2301 S. King Drive
Chicago, IL 60616